2021-07-16
Cost-Effectiveness of Alpelisib for Advanced Breast Cancer in a Dutch Setting
Publication
Publication
Additional Metadata | |
---|---|
Luyendijk, M. | |
hdl.handle.net/2105/62507 | |
Master Health Economics, Policy and Law | |
Organisation | Erasmus School of Health Policy & Management |
Misrielal, A. (2021, July 16). Cost-Effectiveness of Alpelisib for Advanced Breast Cancer in a Dutch Setting. Master Health Economics, Policy and Law. Retrieved from http://hdl.handle.net/2105/62507
|